DRUGS USED IN THE TREATMENT OF CANCER AND NEPHROTOXICITY

Antineoplastik ilaçlar vücutta patolojik biçimde çoğalmakta olan kanser hücrelerini yok ettikleri gibi, hızlı biçimde çoğalmakta olan normal hücreleri de yok ederler. Bu nedenle çoğu kanser ilacının kemik iliği, kan hücreleri ve diğer hızlı çoğalan hücreleri içiren dokular üzerine de yan etkileri vardır. Böbrek hücrelerinin bölünme hızı yüksek olmamasına rağmen, yüksek kan akımı ile karşılaşması, medüller interstisyumda toksinleri konsantre etme yeteneği ve tübüler epitelde spesifik taşıyıcılara sahip olması nedeniyle toksik zedelenmeye oldukça duyarlıdır. Bu derlemede kanser tedavisinde kullanılan ilaçlara bağlı böbrek bozukluğunu ve nefrotoksisitesi en sık gözlenen kanser ilaçlarının nefrotoksik etki mekanizmalarını değerlendirmeyi amaçladık. Antineoplastic drugs that destroy rapidly dividing tumor cell, but also destroy rapidly dividing normal cells. Thus most of antineoplastic drugs have unwanted efects on bone marrow, blood cells and the other tissue that contain rapidly dividing cells. Renal cells have low dividing rate, however they are highly sensitive to toxic damage, because high renal blood flow, capabilty of consantraiting toxin in medullary interstitium and spesific transporting proteins in tubuler epitelium. In this paper we aim to review renal impairment due to the drugs used in canser treatment and the mechanism of actio

Acanthosis Nigricans in a Patient with Lung Cancer: A Case Report

Some skin lesions may accompany malignancies. Acanthosis nigricans, one such lesion, is a paraneoplastic dermatosis characterized by hyperpigmented and velvety verrucose plaques observed as symetric eruptions. With this report, we aim to present a rare case of concomitant lung cancer and acanthosis nigricans. Malignant acanthosis nigricans is most commonly associated with intra-abdominal malignancies. A 65-year-old patient who had hyperpigmented, hypertrophic and symmetric verrucose lesions at the flexor surfaces of the lower and upper extremities, face, palms and the axillary region. Thoracic computed tomography demonstrated a hypodense mass lesion with a dimension of 5 × 5.5 cm at the center of basal segment bronchi of the left pulmonary lobe. Fiberoptic bronchoscopy showed that the access to the lower left lobe was almost completely obstructed by the endobronchial lesion. The result of the histopathologic examination of the endobronchial tissue biopsy was reported as non-small cell (adenocarcinoma) lung cancer. Result of the histopathologic analysis of the punch biopsy of the skin lesions was reported as acanthosis nigricans .There are no pathognomonic dermatological findings for lung cancer. In conclusion, there are skin lesions that accompany lung cancer and we believe that these should be considered for differential diagnosis

A low-cost miniature immunosensor for haemoglobin as a device for the future detection of gastrointestinal bleeding

Gastrointestinal bleeding (GIB) is a serious medical condition, which requires immediate attention to establish the cause of the bleeding. Here, we present the development of a miniaturised electrochemical impedance spectroscopy (EIS) device for the detection of GIB. The device performs EIS measurements up to 100 kHz. Following the development of an immunosensor for haemoglobin (Hb) on screen printed electrodes, the EIS device was used for detecting Hb as an early indication of bleeding. The sensor was able to detect Hb in a redox solution in a linear range between 5 μg mL−1 and 60 μg mL−1, with a limit of detection of 13.3 μg mL−1. It was also possible to detect Hb in simulated intestinal fluid, without the need for a redox solution, within a range of 10 μg mL−1 to 10 mg mL−1 with a limit of detection of 2.31 mg mL−1. The miniature EIS device developed in this work is inexpensive, with an estimated cost per unit of £30, and has shown a comparable performance to existing commercial tools, demonstrating its potential to be used in the future as an ingestible sensor to detect GIB. All these measurements were carried out in a purpose built flow cell with supporting hardware electronics outside the cell. Integration of the hardware and the sensing electrodes was demonstrated in pill form. This pill after integration sampling fluidics has potential to be used in detecting gastrointestinal bleeding

Mitral Valve Repair in Pediatric Patients with Dilated Cardiomyopathy and Mitral Insufficiency: Single-Center Experience and Results

Objective: Idiopathic dilated cardiomyopathy (DCM) is a serious disease causing mitral regurgitation and contraction defects of the myocardium. Through mitral valve (MV) repair surgery, the clinical status of patients can be improved. Methods: Pediatric patients with DCM and mitral insufficiency who underwent mitral repair procedures between 2019 and 2023 were retrospectively investigated. The patients’ demographic characteristics, preoperative and postoperative clinical conditions, and echocardiographic findings were compared. The techniques used in patient operations were examined. Similarly, data regarding the postoperative intensive care unit processes and mortality data of the patients were recorded. Results: Mitral repair was performed in 3 patients during the study period. The mean age of the patients was 4.66 months (±3.05) and body weight was 5.25 kg (±0.25). In the preoperative period, left ventricular ejection fraction decreased slightly in all patients [mean: 43.3% standard deviation (SD): ±2.8]. Although the preoperative and postoperative values of left ventricular end-diastolic diameter (LVEDd) and LVEDd Z-scores were above normal, respectively, they showed a decreasing trend after the operation. Although the mitral annulus diameters decreased slightly after the operation in all three patients, they remained high (mean: 17.6 mm SD: ±1.5). A significant decrease in MV insufficiency was observed in postoperative follow-ups after discharge (1st-2nd degree). Wooler annuloplasty and posterior valve pericardial patch augmentation were applied as the primary approach in all patients. The patients did not develop additional morbidities, and no mortality was observed during hospitalization. Conclusion: Successful surgical interventions to prevent mitral regurgitation in pediatric patients with DCM and mitral regurgitation, may improve the clinical status of these patients

Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort study

Background: Surgical site infection (SSI) is one of the most common infections associated with health care, but its importance as a global health priority is not fully understood. We quantified the burden of SSI after gastrointestinal surgery in countries in all parts of the world. Methods: This international, prospective, multicentre cohort study included consecutive patients undergoing elective or emergency gastrointestinal resection within 2-week time periods at any health-care facility in any country. Countries with participating centres were stratified into high-income, middle-income, and low-income groups according to the UN's Human Development Index (HDI). Data variables from the GlobalSurg 1 study and other studies that have been found to affect the likelihood of SSI were entered into risk adjustment models. The primary outcome measure was the 30-day SSI incidence (defined by US Centers for Disease Control and Prevention criteria for superficial and deep incisional SSI). Relationships with explanatory variables were examined using Bayesian multilevel logistic regression models. This trial is registered with ClinicalTrials.gov, number NCT02662231. Findings: Between Jan 4, 2016, and July 31, 2016, 13 265 records were submitted for analysis. 12 539 patients from 343 hospitals in 66 countries were included. 7339 (58·5%) patient were from high-HDI countries (193 hospitals in 30 countries), 3918 (31·2%) patients were from middle-HDI countries (82 hospitals in 18 countries), and 1282 (10·2%) patients were from low-HDI countries (68 hospitals in 18 countries). In total, 1538 (12·3%) patients had SSI within 30 days of surgery. The incidence of SSI varied between countries with high (691 [9·4%] of 7339 patients), middle (549 [14·0%] of 3918 patients), and low (298 [23·2%] of 1282) HDI (p < 0·001). The highest SSI incidence in each HDI group was after dirty surgery (102 [17·8%] of 574 patients in high-HDI countries; 74 [31·4%] of 236 patients in middle-HDI countries; 72 [39·8%] of 181 patients in low-HDI countries). Following risk factor adjustment, patients in low-HDI countries were at greatest risk of SSI (adjusted odds ratio 1·60, 95% credible interval 1·05–2·37; p=0·030). 132 (21·6%) of 610 patients with an SSI and a microbiology culture result had an infection that was resistant to the prophylactic antibiotic used. Resistant infections were detected in 49 (16·6%) of 295 patients in high-HDI countries, in 37 (19·8%) of 187 patients in middle-HDI countries, and in 46 (35·9%) of 128 patients in low-HDI countries (p < 0·001). Interpretation: Countries with a low HDI carry a disproportionately greater burden of SSI than countries with a middle or high HDI and might have higher rates of antibiotic resistance. In view of WHO recommendations on SSI prevention that highlight the absence of high-quality interventional research, urgent, pragmatic, randomised trials based in LMICs are needed to assess measures aiming to reduce this preventable complication

Detection and elimination of cellular bottlenecks in protein-producing yeasts

Yeasts are efficient cell factories and are commonly used for the production of recombinant proteins for biopharmaceutical and industrial purposes. For such products high levels of correctly folded proteins are needed, which sometimes requires improvement and engineering of the expression system. The article summarizes major breakthroughs that led to the efficient use of yeasts as production platforms and reviews bottlenecks occurring during protein production. Special focus is given to the metabolic impact of protein production. Furthermore, strategies that were shown to enhance secretion of recombinant proteins in different yeast species are presented

Stability Characteristics of a Turbulent Nonpremixed Conical Bluff Body Flame

The thermal characteristics of turbulent non-premixed methane flames were investigated by four burner heads with the same exit diameter but different heights. The fuel flow rate was kept constant with an exit velocity of 15 m/s, while the co-flow air speed was increased from 0 to 7.6 m/s. The radial profiles of the temperature and flame visualizations were obtained to investigate the stability limits. The results evidenced that the air co-flow and the cone angle have essential roles in the stabilization of the flame: An increase in the cone angle and/or the co-flow speed deteriorated the stability of the flame, which eventually tended to blow off. As the cone angle was reduced, the flame was attached to the bluff body. However, when the cone angle is very small, it has no effect on stability. The mixing and entrainment processes were described by the statistical moments of the temperature fluctuations. It appears that the rise in temperature coincides with the intensified mixing, and it becomes constant in the entrainment region.</jats:p

Study on the Effects of Cone Height on the Turbulent Nonpremixed Flames Downstream of a Conical Bluff Body

Abstract Flow, thermal, and emission characteristics of turbulent nonpremixed CH4 flames were investigated for three burner heads of different cone heights. The fuel velocity was kept constant at 15 m/s, while the coflow air speed was varied between 0 and 7.4 m/s. Detailed radial profiles of the velocity and temperature were obtained in the bluff body wake at three vertical locations of 0.5D, 1D, and 1.5D. Emissions of CO2, CO, NOx, and O2 were also measured at the tail end of every flame. Flames were digitally photographed to support the point measurements with the visual observations. Fifteen different stability points were examined, which were the results of three bluff body variants and five coflow velocities. The results show that a blue-colored ring flame is formed, especially at high coflow velocities. The results also illustrate that depending on the mixing at the bluff-body wake, the flames exhibit two modes of combustion regimes, namely fuel jet- and coflow-dominated flames. In the jet-dominated regime, the flames become longer when compared with the flames of the coflow-dominated regime. In the latter regime, emissions were largely reduced due to the dilution by the excess air, which also surpasses their production.</jats:p